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ABSTRACT: Reliable antimicrobial susceptibility testing is
essential in informing both clinical antibiotic therapy decisions
and the development of new antibiotics. Mammalian cell culture
media have been proposed as an alternative to bacteriological
media, potentially representing some critical aspects of the
infection environment more accurately. Here, we use a
combination of NMR metabolomics and electron microscopy to
investigate the response of Escherichia coli and Pseudomonas
aeruginosa to growth in differing rich media to determine whether
and how this determines metabolic strategies, the composition of
the cell wall, and consequently susceptibility to membrane active
antimicrobials including colistin and tobramycin. The NMR
metabolomic approach is first validated by characterizing the
expected E. coli acid stress response to fermentation and the accompanying changes in the cell wall composition, when cultured in
glucose rich mammalian cell culture media. Glucose is not a major carbon source for P. aeruginosa but is associated with a response
to osmotic stress and a modest increase in colistin tolerance. Growth of P. aeruginosa in a range of bacteriological media is supported
by consumption of formate, an important electron donor in anaerobic respiration. In mammalian cell culture media, however, the
overall metabolic strategy of P. aeruginosa is instead dependent on consumption of glutamine and lactate. Formate doping of
mammalian cell culture media does not alter the overall metabolic strategy but is associated with polyamine catabolism, remodelling
of both inner and outer membranes, and a modest sensitization of P. aeruginosa PAO1 to colistin. Further, in a panel of P. aeruginosa
isolates an increase between 2- and 3-fold in sensitivity to tobramycin is achieved through doping with other organic acids, notably
propionate which also similarly enhances the activity of colistin. Organic acids are therefore capable of nonspecifically influencing the
potency of membrane active antimicrobials.
KEYWORDS: antimicrobial susceptibility testing, NMR metabolomics, colistin
The effective development of new antibiotics to combat therise in infections due to antimicrobial resistant bacteria is
dependent on antimicrobial susceptibility screening being a
reliable predictor of therapeutic outcomes. Recently the use of
the universal media standard Mueller-Hinton Broth (MHB) for
in vitro efficacy testing, as recommended by the Clinical and
Laboratory Standards Institute,1 has been challenged since this
does not replicate the nutritional environment provided by the
host and hence does not predict patient outcomes. The use of
MHB can produce both false-positive and false-negative results.
For example, Salmonella has been shown to be sensitive to
polymyxin in MHB but it induces polymyxin resistance during
infection.2 In contrast, azithromycin, which lacks activity against
Gram-negative bacteria in MHB, was shown to be effective
against multidrug resistant (MDR) strains of Pseudomonas
aeruginosa,Klebsiella pneumoniae, andAcinetobacter baumannii in
eukaryotic cell culture media RPMI-1640 and in murine
infection models.3 Consequently, antibacterial testing has been
conducted in a variety of cell culture media to identify readily
available media that generate results that are more predictive of
in vivo therapeutic outcomes.4
A complementary approach has been to work to define the key
elements of the host nutritional environment from the bacterial
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perspective. The essential genome5 and transcriptome during
infection6−8 has been described for P. aeruginosa as has, more
recently, the Staphylococcus aureus transcriptome during Cystic
Fibrosis (CF) lung infection.9 Metabolomics has also been
employed to understand how P. aeruginosa adapts to varying
environments10 and, in understanding its particular metabolic
requirements during pulmonary infections, notably of CF
patients,11 and this understanding is recognized both as being
a route to more effective therapy9 and patient outcomes.12
These efforts have led to the development of complex, synthetic
media that better reflect the nutritional environment in, for
example, the CF lung infection setting.5,12,13 These may be
further adapted to include components of the host innate
immune system.7 In addition, ex vivo porcine lung models are
being developed that recapitulate the spatial structure and
nutritional environment of the host organ14,15 and which may
better represent features of clinical disease.16
Establishing a mechanistic basis for bacterial species and/or
strain-dependent environmental variation in antibiotic suscept-
ibility will aid the development of chemically defined media that
can more reliably predict therapeutic outcomes but also will
contribute to rational antibiotic design. The present study aims
to provide a mechanistic understanding of altered susceptibility
to membrane active antibiotics, in particular to identify which
components of bacterial and cell culture media have the greatest
influence on cell wall structure. Since the production of most
high energy compounds occurs at the bacterial plasma
membrane, we hypothesize that altered metabolic strategy is
likely to affect the composition of the bacterial cell envelope and
may have a concomitant impact on susceptibility to antibiotics
that act on these structures. We therefore chose to study the
effect of culturing two Gram-negative bacteria, in a range of
bacteriological media as well as RPMI-1640 (RPMI), on the
metabolic strategy, the cellular metabolite composition and
susceptibility to membrane active antibiotics. We use 1H NMR
of spent culture media to provide an overview of the metabolism
of Escherichia coliNCTC 9001 and P. aeruginosa PAO1 inMHB,
cation-adjusted MHB (CAMHB), Luria−Bertani (LB), Tryp-
tone Soya Broth (TSB) and RPMI with 5% fetal bovine serum
(FBS), and 1H high resolution magic angle spinning (HR-MAS)
NMR of whole cells to describe changes in the cellular
metabolite including the cell wall composition. The HR-MAS
is supported by transmission electron microscopy (TEM) that
shows how cell morphology is altered in the same conditions.
Our study of E. coliNCTC 9001 is sensitive to fermentation and
detects components of the previously well characterized acid
stress response and this served to validate the usefulness of the
NMR technique. Applying the same technique to P. aeruginosa,
we characterize the metabolism of a panel of six isolates in MHB
and RPMI and develop and test hypotheses regarding the effects
of key components of bacteriological media and RPMI. Using a
combination of both NMR methods and TEM, we show how
the cell wall composition changes in response to the availability
of formate, present in and consumed from all bacteriological
media but largely absent from RPMI, and how this and other
organic acids influence antibiotic sensitivity/tolerance.
■ RESULTS
Antibiotic Susceptibility of E. coli NCTC 9001 and P.
aeruginosa PAO1 to Membrane Active Antimicrobials Is
Strongly Influenced by Culture Conditions. To better
understand how variations in metabolism and cell wall
composition might impact on the potency of membrane active
antimicrobials with differing mechanisms of action we selected
four well-characterized antimicrobial peptides (AMPs) and
assessed their potency in five different media against two
representative Gram-negative bacterial isolates: uropathogenic
E. coliNCTC9001 and P. aeruginosa PAO1 (Table 1). LL-37 is a
very well-studied human host defense peptide (HDP) with a
multifaceted role in innate immunity.17−19 Magainin 2 is
perhaps the archetypal membrane damaging AMP.20−22 Pleuro-
cidin, generally more potent toward Gram-negative than Gram-
positive bacteria in MHB,23 is considered to have the ability to
penetrate within bacteria as well as membrane damaging
properties.23−27 Colistin is a clinically relevant, polycationic
cyclic polymyxin peptide considered the last-resort for multi-
drug-resistant Gram-negative infections. Although colistin is
widely considered to act by disruption of the outer membrane
integrity through displacement of Mg2+ and Ca2+ and binding to
lipid A,28 polymyxins have also been suggested to insert into the
plasma membrane,29 and fluorescently labeled analogues of
polymyxin B have been shown to penetrate within Gram-
negative bacterial cells.30 More recently, the discovery that
MCR-1 mediated colistin resistance is dependent on the
modification of cytoplasmic membrane associated lipopolysac-
charide (LPS) and not that located at the outer membrane has
enabled the demonstration that it is the targeting of cytoplasmic
membrane bound LPS on which the bactericidal activity of
colistin depends.31 Against either isolate, all four AMPs are most
potent when tested in MHB. The potency of the linear AMPs
(LL-37, pleurocidin, and magainin 2) is frequently substantially
reduced both in the other three bacteriological media and
RPMI. Although the effect is much more modest, the potency of
colistin is also significantly reduced in the other media.
MHB is commonly adjusted with additional Mg2+ and Ca2+ to
increase the concentration of each respectively from 228 and 73
Table 1. Effect of Media on Susceptibility to Membrane Active Antimicrobialsa
E. coli NCTC 9001 P. aeruginosa PAO1
LL-37 Pleurocidin Magainin 2 Colistin LL-37 Pleurocidin Magainin 2 Colistin
MHB 1.48 ± 0.19 0.90 ± 0.07 1.76 ± 0.05 0.12 ± 0.01 7.21 ± 0.59 6.02 ± 0.11 30.30 ± 0.94 0.51 ± 0.04
CAMHB 3.71 ± 0.67 3.66 ± 0.24 7.00 ± 0.11 0.17 ± 0.02 >14 >49 >55 1.08 ± 0.07
LB 1.76 ± 0.06 2.57 ± 0.28 3.91 ± 0.33 0.22 ± 0.01 >14 20.6 ± 1.54 32.4 ± 0.11 0.76 ± 0.08
TSB 14.0 ± 1.70 0.83 ± 0.21 3.96 ± 0.22 0.16 ± 0.04 >128 18.0 ± 5.74 >256 1.27 ± 0.26
RPMI >14 3.64 ± 0.39 22.4 ± 1.45 0.20 ± 0.02 >14 >49 >55 1.22 ± 0.09
aThe minimal inhibitory concentration (MIC) for selected antimicrobial peptides against E. coli NCTC 9001 or P. aeruginosa PAO1 is reported in
micromolar for selected antimicrobial peptides as an average ± standard error of three independent repeats. Buforin II was also tested in all media
except for TSB. Only in LB against E. coli NCTC 9001 could an MIC (26.6 ± 0.9) be found as in all other conditions no inhibitory effect was
observed. Values in bold are significantly different (p < 0.05) with respect to the corresponding MHB condition as determined by one-way ANOVA
with Bonferroni post-hoc test.
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μM to 514 and 624 μM in CAMHB and this is known to impact
on the potency of AMPs.1,32 Cation adjustment affects the
sensitivity of both isolates to the linear AMPsmuchmore than to
colistin. Both pleurocidin and magainin 2 experience a 4-fold
reduction in sensitivity against E. coliNCTC9001, and against P.
aeruginosa PAO1 the potency is reduced below the limit of
detection. The cation adjustment effect on LL-37 activity against
E. coli NCTC 9001 is more moderate but activity against P.
aeruginosa PAO1 is attenuated in the range of concentrations
tested. In contrast, the activity of colistin toward E. coli NCTC
9001 is largely unaffected by cation supplementation. LB has a
similar Mg2+ and Ca2+ composition to MHB before cation
adjustment (Table S1). The reduction in potency of both
pleurocidin and magainin 2 against both isolates, and LL-37
against P. aeruginosa PAO1, in this media is then due to other
factors.
Colistin, though less sensitive to the use of differing media, is
less effective in RPMI when compared with MHB where the
MIC is approximately double. Except for the activity of
pleurocidin against E. coli NCTC 9001, activity of the linear
AMPs is drastically reduced in RPMI. The concentrations of
Mg2+ (410 μM) and Ca2+ (420 μM) in RPMI are a little lower
than in CAMHB but much greater than in either MHB or LB
and can be expected to contribute to the reduced potency of the
linear AMPs in the mammalian cell culture media. Additionally,
a contribution from bacterial and/or serum proteases to
neutralizing linear AMP activity can be expected; recently we
compared pleurocidin and its D-amino acid analogue and found
the D-enantiomer offered gains in potency, relative to the L-
enantiomer, against a range of Gram-negative isolates in RPMI
but not in MHB.23 Nevertheless, the observation that pleuro-
cidin retains some useful activity in RPMI against E. coli NCTC
9001 but that this is not reproduced for P. aeruginosa PAO1
shows the effect of cation adjustment and protease activity are
insufficient to explain the species specific susceptibility pattern.
We therefore characterized metabolism in the microbiological
media and RPMI to identify metabolic-dependent features of
the bacterial envelope that may be associated with altered
sensitivity to AMPs.
Altered Cell Wall Composition in E. coli NCTC 9001
Grown in RPMI Is Associated with an Acid Stress
Response. A combination of transmission electron microscopy
(TEM) (Figure 1A,B) and NMR spectroscopy (Figure 1C−E;
Figure S1A−C) was used to study the response of E. coliNCTC
9001 to culture in four different bacteriological media or RPMI.
Studying the spent culture metabolome suggests that a
combination of fermentation and anaerobic respiration is
employed in MHB (Figure 1). There is little glucose in MHB
but this, together with serine and threonine, is consumed and
fermented to acetate (see Figure 2 for pathway overview).
Figure 1. Glucose fermentation initiates an acid stress response in E. coli NCTC 9001. Transmission electron micrographs for E. coli NCTC9001
grown in MHB (A) or RPMI (B); wider field images are shown in Figure S2. Volcano plots obtained from liquid state 1H NMR of spent bacterial
culture reveal the metabolic strategy of E. coli NCTC 9001 in MHB (C) or RPMI (D). 1H HR-MAS NMR of bacterial pellets enables comparison of
the effect on cellular metabolites of growth in MHB or RPMI (E). Scale bars represent 200 nm.
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Formate is an important electron donor for anaerobic
respiration while nitrate, nitrite, and/or fumarate are common
electron acceptors (Figure 2). The consumption of formate is
therefore indicative of formate dehydrogenase activity while the
consumption of aspartate and production of succinate are
indicative of fumarate reductase activity (Figure 2) and taken
together identify anaerobic respiration as an important feature of
E. coliNCTC9001 growth inMHB. A greater amount of glucose
in TSB (2.5 g/Liter 13.9 mM), and the disaccharide trehalose in
LB are linked to a slightly greater reliance on fermentation with
production of formate and, for TSB only, lactate observed
(Figure S1B/C). However, the consistent consumption of
aspartate and excretion of succinate observed in CAMHB, LB,
and TSB spent cultures (Figure S1A−C) indicates anaerobic
respiration underpins growth of E. coli NCTC 9001 in all four
bacteriological media. In contrast, both the NMR (Figure 1D)
and, more simply, pH measurements of spent culture (Table 2)
indicate that while anaerobic respiration continues, E. coli
NCTC 9001 places much greater reliance on fermentation of
glucose when growing in RPMI. Glucose is present at 2 g/L
(11.1 mM) in RPMI and much of this is fermented to acetate,
formate, and lactate. The result is that the culture is acidified by
more than three pH units to around pH 4.6, approximately two
pH units lower than observed with the bacteriological media.
Enterobacteria including E. coli have stress responses that
enable them to cope with mild and even severe low pH
stress.33,34 Part of the acid stress response includes induction of
amino acid decarboxylases which act to balance pH changes by
consuming a proton during decarboxylation and then exchange
the product for a new substrate via a membrane bound
antiporter. In this way, glutamate is exchanged for GABA (4-
aminobutyrate), arginine for agmatine, lysine for cadaverine, and
ornithine for putrescine. Increased putrescine, cadaverine, and
4-aminobutyrate are detected in spent RPMI culture while
substantial amounts of glutamine, present at 300 mg/L, are also
consumed (Figure 1D). Glutamine can itself be decarboxylated
or it can be deaminated via an acid-activated glutaminase, YbaS,
releasing free ammonia which neutralizes the proton and
yielding glutamate in the cell as a substrate for decarbox-
ylation.35
Figure 2. The major catabolic pathways available to E. coli or P. aeruginosa. Shown are key enzymes involved in anaerobic respiration: formate
dehydrogenase (FDH), succinate dehydrogenase (SDH), nitrate reductase (NR), nitrite reductase (NiR).
Table 2. pH of the Freshly Prepared Sterile Media and after







MHB 7.49 ± 0.02 6.73 ± 0.01 7.87 ± 0.01
CAMHB 7.53 ± 0.02 6.91 ± 0.02 7.63 ± 0.01
LB 7.28 ± 0.01 7.31 ± 0.01 7.76 ± 0.01
TSB 7.30 ± 0.02 6.44 ± 0.02 7.46 ± 0.07
RPMI 7.64 ± 0.03 4.62 ± 0.01 7.93 ± 0.09
RPMI + 40 mM Na
formate
7.32 ± 0.02 NDb 7.95 ± 0.09
aData are from the overnight cultures used for the NMR
metabolomics experiments, described in Figures 2 or 3, presented
as averages ± standard error of mean. bND = not done.
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The glutamate-dependent acid resistance (AR) system, AR2,
is regulated by the DNA-binding transcriptional activator
GadE.36 GadE is itself activated during exponential phase
growth at mildly acidic pH via the two-component system
(TCS) EvgAS which also activates a second TCS, PhoPQ, via
the connector SafA. Consistent with this, spent RPMI culture
Figure 3. Anaerobic respiration and osmotic stress affect cell wall composition in P. aeruginosa PAO1. Hierarchical cluster maps obtained from liquid
state 1H NMR of spent bacterial culture reveal the metabolic strategy of P. aeruginosa in MHB (A) or RPMI (B). Transmission electron micrographs
for P. aeruginosa PAO1 grown inMHB (C) or RPMI (E); wider field images are shown in Figure S2. Scale bars represent 200 nm. 1HHR-MASNMRof
P. aeruginosa PAO1 bacterial pellets enables comparison of the effect on cellular metabolites of growth in MHB or RPMI (D).
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obtained from growth of the ΔevgS mutant of E. coli BW25113,
obtained from the Keio collection, does not undergo the same
level of acidification as the parent (Table S2). PhoPQ is known
to regulate the sensitivity of E. coli to antimicrobial peptides by
controlling EptB, which adds a phosphoethanolamine moiety,
and PagL and PagP, which respectively deacylate and acylate
lipid A.37,38
The production of the exopolysaccharide, colanic acid, or M-
antigen, a negatively charged polymer of glucose, galactose,
fucose, and glucuronic acid that forms a protective capsule, by
UDP-glucose 6-dehydrogenase is controlled by RcsB, which is
required for acid resistance and interacts with GadE.39
Consistent with this, HR-MAS NMR of whole cells shows that
growth of E. coli NCTC 9001 in RPMI causes substantial
changes in the cell wall composition relative to that found when
grown inMHB and specifically increases in the intensity of three
resonances assigned to sugar moieties and an N-acetyl group
(Figure 1E). In support of this finding, TEM images (Figure
1A,B; Figure S2A,B) reveal there is a clear change in the outer
membrane structure (Figure 1A/B). In contrast, analogous
comparisons of HR-MAS spectra obtained for E. coli NCTC
9001 grown in LB, TSB, or CAMHB (Figure S3A−C) show the
cellular metabolite complement is altered substantially in each
case but the major changes attributed to polysaccharide
resonances are lacking. The conformation of LL-37 is pH
dependent with the α-helix conformation and antibacterial
activity lost below pH 5.17,40 While the acidification of the spent
media in TSB is modest (Table 2), this has nevertheless been
shown to be sufficient to have a measurable impact on LL-37
activity against both S. aureus and P. aeruginosa.40 Therefore, the
activity of LL-37 is likely to be impaired by environmental
acidification in TSB and, more strongly, in RPMI. However,
while magainin 2 is only approximately 2-fold less active in TSB
than in MHB it is nearly 13 times less potent in RPMI. The
activity of magainin2 is not known to be inhibited by low pH;
indeed, its anticancer activity is enhanced,41 and hence the
reduction in its activity in RPMI is likely associated with the
acid-stress response of the bacteria and the production of an
additional polysaccharide barrier rather than any direct effect of
pH on behavior of the peptide.
Figure 4. Formate doping of RPMI increases sensitivity of P. aeruginosa PAO1 to colistin and induces cell wall remodelling. The colistin MIC for P.
aeruginosa PAO1 in RPMI decreases as a function of added formate (A). In a broth-microdilution assay, at 5 mM [formate] and above significant
reductions in the MIC are observed (p < 0.05, one-way ANOVA with Bonferroni posthoc test) with an approximately 2-fold reduction in MIC at 40
mM. 1H HR-MAS NMR of bacterial pellets (B) or transmission electron microscopy (C,D) enables comparison of the effect on cellular metabolites
and cell ultrastructure of growth in RPMI with (D) or without (C) 40 mM formate. Scale bars represent 200 nm.
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Altered Cell Wall Composition in P. aeruginosa PAO1
Grown in RPMI Is Associated with Osmotic Stress and
Glucose and Formate Availability. NMR spectroscopy was
also used to investigate the metabolic strategy of six multidrug-
resistant and susceptible clinical P. aeruginosa isolates inMHB or
RPMI, and TEM and HR-MAS NMR were used, as above, to
characterize P. aeruginosa PAO1 (Figure 3; Figure S1D−F). It is
known that, unlike E. coli, P. aeruginosa eschews glucose
consumption.42 In RPMI, some glucose is consumed, and
gluconate and a little acetate is detected in the spent media
(Figure 3B). It is therefore probable that some glucose in RPMI
is being used via the Entner-Doudoroff pathway to support
pyruvate fermentation,43 but the consumption of succinate,
whose presence would repress the expression of genes needed
for assimilation of sugars including gluconate, will limit this.42
Therefore, although the preferred metabolic strategy for P.
aeruginosamay be aerobic respiration, and this may contribute to
growth in the conditions used here, a more substantial role for
anaerobic processes is expected.44 These would include both use
of arginine as an energy source via the arginine deiminase
pathway and anaerobic respiration using a variety of electron
donor and acceptors (Figure 2). Consistent with this, arginine is
consumed, and ornithine excreted by P. aeruginosa PAO1 in all
five media conditions and by all six P. aeruginosa isolates in both
MHB and RPMI (Figure 3A,B; Figure S1D−F). Arginine
consumption may be less in RPMI where glucose may exert
catabolite repression.45 In contrast, while formate is propor-
tionally the most consumedmetabolite in all four bacteriological
media (MHB, CAMHB, LB, and TSB), it is largely absent from
RPMI and hence unavailable as a major substrate (Figure 3B).
Formate dehydrogenase-dependent anaerobic respiration is
therefore identified as a key source of energy for P. aeruginosa
when grown in the four bacteriological media but not RPMI
where growth is instead underpinned by glutamine, asparagine,
and lactate consumption (Figure 3B). P. aeruginosa does not
grow well in RPMI until 5% FBS is added from which lactate is
consumed (Figure 3B). Lactate is an alternative electron donor
for anaerobic respiration and hence growth of P. aeruginosa in
Figure 5. Colistin sensitivity induced by formate doping of RPMI is associated with polyamine catabolism and cell wall remodelling in P. aeruginosa
PAO1. Linear regression analysis, of HR-MASNMRdata withMICs obtained from a separate brothmicrodilution assay, identifies metabolites (A−H)
associated with increased sensitivity to colistin following addition of formate at the concentrations (mM) indicated in the legend for each panel.
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RPMI is likely supported by anaerobic respiration and arginine
catabolism with glutamine and asparagine as major sources of
ammonium.
Despite the similarities in growth strategies used by P.
aeruginosa PAO1 in MHB and RPMI, HR-MAS NMR analysis
again detects substantial differences in the cell wall composition
for cells grown in the two media. Specifically, resonances
assigned to lipids and the osmoprotectant glycine betaine46 are
substantially increased in cells grown in RPMI (Figure 3D).
These findings are supported by the TEM images since cells
grown in RPMI appear more turgid and the cell wall appears
thicker and is much more densely stained (Figure 3C,E; Figure
S2). More modest changes, relative to MHB, were detected by
HR-MAS NMR for cells grown in LB or TSB though there is a
notable increase in glycine betaine for the latter (Figure S3D,E).
Consistent with this, cells grown in TSB appear more turgid but
there is little change in the thickness or staining of the cell wall
(Figure S4). Consequently, in addition to characterizing the
effect of increasedMg2+ and Ca2+ on the cell wall in P. aeruginosa
PAO1 (Figure S5) we investigated the effect of glucose addition
to MHB (Figure S6), and formate addition to RPMI (Figure 4/
5), to isolate the contributions of these nutrients to the different
phenotypes observed in MHB and RPMI. Titration of Ca2+ and
Mg2+ in MHB to levels that match and then surpass those found
in RPMI (though a little lower than in CAMHB) induces little
change in the susceptibility of P. aeruginosa PAO1 to colistin
(Figure S5B).
HR-MAS NMR nevertheless identifies substantial changes in
the cellular metabolite complement including increased
intensity of resonances assigned to lipids (Figure S5D). In
contrast, addition of glucose to MHB was associated with a
modest increase in tolerance to colistin and an increase in the
osmoprotectant glycine betaine but no effect on cell wall
components (Figures S6 and S7).
Increased Sensitivity of P. aeruginosa to Membrane
Active Antimicrobials Is a Nonspecific Effect of Doping
with Organic Acids. When formate is added to RPMI, very
little is consumed but its addition has profound effects on cell
wall composition in P. aeruginosa PAO1 and is strongly
correlated with a modestly increased susceptibility to colistin
(Figure 4) despite a relatively modest impact on the overall
metabolic strategy (Figures S8 and S9). Addition of formate
correlates with an approximate two-fold decrease in colistin
sensitivity and the relationship is best described by a logarithmic
transform (Figure 4A). Low doses of formate to RPMI, a final
concentration of 10 mM or less, caused only modest changes in
metabolites excreted or consumed by P. aeruginosa PAO1
(Figures S8 and 9). At 20 mM [formate] and above, these
changes become more substantial (Figure S8) but the metabolic
strategy is not fundamentally changed (Figure S9). Increased
production of propionate and 3-hydroxyisobutyrate is notable as
is increased consumption of choline and amino acids including
histidine, isoleucine, leucine, methionine, phenylalanine,
threonine, tyrosine, and valine. Production of aspartate,
glutamate, pyruvate, and lysine is halted and production of
ornithine decreases. However, the large-scale consumption of
arginine and glutamine is unaffected, increases in lactate
consumption are modest, and there is no effect on succinate
consumption. Consistent with this, no significant effect of
formate addition can be observed in DCFH-DA fluorescence as
a measure of ROS/RNS generation and a possible indicator of
nitrate or nitrite reductase activity; this is modestly if
significantly lower in RPMI compared with MHB (Figure S8D).
In contrast with the liquid state NMR, at 5 mM [formate] and
above, HR-MASNMR of cells grown in RPMI with and without
formate detects substantial reductions in the intensity of
resonances assigned to lipids (Figure 4B). Consistent with
this, the corresponding TEM of P. aeruginosa PAO1, grown in
RPMI with and without 40 mM [formate], shows the cells to be
similarly turgid but the staining of the inner and outer
membrane is noticeably denser in the absence of formate
(Figure 4C,D). Additionally, HR-MAS identifies reduced
cellular aspartate and increased succinate, 1,3-diaminopropane,
and 4-aminobutyrate (also known as γ-aminobutyric acid or
GABA). These last two metabolites are both associated with
spermine and spermidine catabolism and hence polyamine
Table 3. Effect of Different Media and Organic Acids on Susceptibility of a Panel of P. aeruginosa Isolates to Tobramycin or
Colistina
RPMI + 40 mM organic acid
P. aeruginosa isolate TSB MHB RPMI Formate Butyrate Acetate Citrate Propionate
Tobramycin
372261 2 2 2 1 1 1 1 1
CAS2 4 4 4 2 2 2 1 2
CAS3 4 2 4 2 2 1 1 1
CAS4 4 3 4 4 2 2 2 2
GH12 >128 >128 >128 >128 >128 >128 >128 >128
PAO1 2 2 4 2 2 1 1 2
Average* ± SE 3.2 ± 0.5 2.8 ± 0.5 3.6 ± 0.4 2.2 ± 0.5 1.8 ± 0.2 1.4 ± 0.2 1.2 ± 0.2 1.6 ± 0.2
Colistin
372261 1 2 2 1 2 1 16 1
CAS2 1 4 2 2 1 16 8 1
CAS3 0.5 2 1 1 1 1 1 0.5
CAS4 1 4 2 1 2 1 1 1
GH12 0.5 4 2 2 2 2 2 1
PAO1 1 1 2 1 1 2 1 1
Average ± SE 0.8 ± 0.1 2.8 ± 0.5 1.8 ± 0.2 1.3 ± 0.2 1.5 ± 0.2 3.8 ± 2.4 4.8 ± 2.5 0.9 ± 0.1
aConcordant MICs are provided from three independently repeated experiments. For sensitive strains only, an average MIC is provided in each
condition and significant differences relative to RPMI, as determined by One-way ANOVA with Geisser-Greenhouse correction and Dunnett’s
multiple comparisons test, in bold. RPMI conditions all contain 5% FBS.
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degradation. GABA is also a product of putrescine degradation
and can be further degraded to succinate.47
Although no MIC could be determined for the three linear
AMPs in RPMI, this data was available for colistin and could also
be determined, at various formate concentrations, in a separate
brothmicrodilution assay. PLS regression between theHR-MAS
NMR metabolomic data and MIC as a function of formate
concentration (Figure 5) and Spearman correlations were
calculated between all metabolites quantified in the formate
titration experiment (Figure S10). A good model was obtained
(Q2 = 0.370; R2 = 0.944; Figure S11) with the variance of 11
metabolites correlating (p < 0.05) with the averageMIC (Figure
5; Figure S11). The strongest correlation with the decreasing
MIC is obtained with 1,3-diaminopropane, lysine, and a
resonance assigned to an N-acetyl group (Figure 5A,C). A
similar trend is also observed for GABA (Figure 5B; p = 0.0581).
Weaker correlations are observed with lipid resonances (Figure
5F−H), succinate (Figure 5E) and aspartate, alanine, phenyl-
alanine and acetate (Figure S11). The correlation between the
colistin MIC and betaine is relatively weak (p = 0.0861). The
decreased tolerance to colistin with increasing formate
concentration is therefore most closely associated with poly-
amine degradation though the remodelling of the plasma
membrane may also contribute.
Since the formate-dependent sensitization of P. aeruginosa
PAO1 to colistin was achieved in the absence of a fundamental
change in metabolism we hypothesized that this might be a
generic effect, achievable with other organic acids, that might
impact the activity of other membrane active antimicrobials. We
therefore obtained MICs for both colistin and the aminoglyco-
side tobramycin for the six P. aeruginosa isolates in MHB, TSB,
and RPMI (5% FBS) alone or containing 40 mM formate,
butyrate, acetate, citrate, or propionate (Table 3). GH12 is
resistant to tobramycin (MIC > 128 μg/mL) but the five other
strains are sensitive and the MICs in RPMI are consistently
reduced through the addition of the five organic acids. Two-fold
reductions in MIC are observed in all but one instance and four-
fold reductions observed in the presence of acetate, citrate and
propionate. The impact of the five organic acids on colistin
MICs are more variable and, when potentiating, more modest.
Substantial increases in colistinMIC are observed for two strains
(372261 and CAS2) in the presence of citrate, while acetate
produces the same effect for CAS2 only. Notably, however,
propionate consistently induces a 2-fold reduction in colistin
MIC.
■ DISCUSSION
The present study shows that the combination of both liquid and
HR-MASNMR spectroscopy, supported by TEM, is an effective
means of characterizing the metabolic strategies of bacteria in
varying growth conditions and can be used to identify
contributions of individual nutrients to antimicrobial suscept-
ibility phenotypes. The acid stress response of E. coli has been
described in some depth previously and its characterization for
E. coliNCTC9001 in glucose rich (11.1mM)RPMI, serves here
to validate the approach and to indicate that, in glucose rich
infection settings, we may expect AMPs to face substantial
amounts of colanic acid as an additional barrier. Since the acid
stress response is more muted in similarly glucose rich TSB
(13.9 mM), its fermentation and consequent acidification of the
environment will depend on the availability of other nutrients. In
urine, glucose concentrations are normally low, less than 0.7mM
in healthy subjects but can exceed 2.5 mM in patients with
diabetes or kidney disease.48 In blood, glucose is normally
available in the low millimolar range (3.9 to 5.8 mM) when
fasting but exceeds 7 mM in diabetics.49 Therefore, since
exposure of E. coli to sublethal doses of AMPs is known to trigger
production of colanic acid (and curli) and such priming confers
tolerance and persistence,50 in vitro susceptibility testing,
capable of predicting in vivo success against E. coli by AMPs in
such settings, may therefore incorporate glucose to trigger the
production of this barrier.
The NMR metabolomic approach was also capable of
describing the metabolic strategy of P. aeruginosa PAO1 in the
same varying growth conditions, additionally isolating the role of
three key nutrients, a combination of the divalent cations Ca2+
andMg2+, glucose, and formate, in determining the composition
of the cell wall and susceptibility to AMPs including colistin. The
relative importance of each of these for susceptibility testing of P.
aeruginosa can therefore be considered.
Cation adjustment of MHB is known to inhibit the activity of
AMPs.33 Here, the addition of divalent cations to MHB affected
the activity of linear AMPs but had minimal impact on the
activity of colistin. The reduction of activity of the linear AMPs
against P. aeruginosa PAO1 can be attributed to changes in,
predominantly, lipids which is consistent with the requirement
for the plasma membrane to be damaged or crossed as the key
element of their mechanisms of action. Consequently, it might
be appropriate to recommend cation adjustment if this were to
accurately model the in vivo conditions. However, cation
adjustment alone is unlikely to predict in vivo activity for both
E. coli and P. aeruginosa since the effect of cation adjustment on
P. aeruginosa is more profound than on E. coli and it does not
reproduce the same reduction in potency for LL-37 or magainin
2 against E. coli NCTC 9001 as found in RPMI, which may be
related to the acid stress response discussed above. Addition of
Ca2+ and Mg2+ to MHB up to and beyond the levels found in
RPMI did not significantly increase theMIC of colistin against P.
aeruginosa PAO1. Only at the highest [Ca2+] and [Mg2+] found
in CAMHB was a significant, if modest, increase observed. This
is despite substantial changes in the plasma membrane lipid
composition and even signals that may be attributed to LPS
and/or EPS. If penetration of the plasma membrane by colistin
contributes substantially to its bactericidal action,29,30 then the
observed changes in cellular metabolite composition might be
expected to have more impact. However, the recent discovery
that colistin targets cytoplasmic membrane bound LPS puts
these findings in new light since they imply that cytoplasmic
membrane bound LPS may not be affected in the same way as
outer membrane bound LPS, reducing the sensitivity of colistin
to changes in environmental Ca2+ and Mg2+.
Glucose Availability Will Influence Osmotic Potential.
Glucose is considered to be available in millimolar concen-
trations in CF sputum.51 However, although it may be an
important carbon source for some species, for P. aeruginosa
glucose is considered a secondary carbon source.8 Instead, its
preferred carbon sources are proline, alanine, arginine, lactate,
glutamate, and aspartate,51 and expression of P. aeruginosa
lactate dehydrogenase is increased in vivo in cystic fibrosis
lungs.7,8 In the present study, arginine and lactate are all
consumed from RPMI by the six P. aeruginosa isolates in
addition to, most notably, glutamine and asparagine. Glutamine
(2 mM) and asparagine (0.38 mM) are likely important sources
of ammonium in RPMI and can be compared with the 2.3 mM
NH4
+ available in synthetic cystic fibrosis medium (SCFM).51
Their catabolism likely explains the excretion of aspartate and
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glutamate into the spent media. Succinate, consumed by P.
aeruginosa PAO1 and, to a lesser extent, by the other five isolates,
is an important intermediate in the tricarboxylic acid (TCA)
cycle but also the glyoxylate shunt. The latter enables P.
aeruginosa to bypass the complete TCA cycle, in particular its
CO2 generating steps, conserve carbon for gluconeogenesis, and
reduce electron flow into respiration.52 Supplementing the
shunt would aid in overcoming oxidative stress.52 RPMI also
contains 1.2mMNO2
−, available from 100mg/Liter Ca(NO3)2,
and hence the consumption of lactate as an electron donor is
consistent with anaerobic respiration and denitrification as
characterized in sputum samples.8 Therefore, although there are
differences in the composition of RPMI and media designed to
better reflect the CF infection setting, the overall metabolic
strategy of P. aeruginosa in these conditions and in sputum is
similar. Glucose availability thus does not have a substantial
effect on P. aeruginosa metabolism beyond an apparent osmotic
effect associated with the production of glycine-betaine and a
more turgid appearance in TEM.
Sensitization of P. aeruginosa to Colistin or Tobramy-
cin by Formate and Other Organic Acids. Addition of
formate to RPMI has a profound effect on the lipid composition
of P. aeruginosa PAO1 and modestly reduces its tolerance of
colistin. The effect on the metabolic strategy is however not so
profound and other organic acids can produce the same, modest
sensitization of P. aeruginosa to colistin or the aminoglycoside
tobramycin. The availability of formate or other organic acids in
RPMI may therefore have a nonspecific effect and consideration
of the nature of the changes in metabolites that are detected and
that correlate with formate-induced colistin sensitivity support
this. Significant changes in the cell metabolite complement
occurred at 5 mM [formate] and this coincides with significant
reduction in tolerance to colistin. Increased succinate is
identified intracellularly but there are no substantial changes
in its consumption from the media and its intracellular
concentration correlated only weakly with the MIC. This is
perhaps because increased intracellular succinate could have
multiple causes: (1) redirection of arginine metabolism from the
arginine iminase to the arginine succinyltransferase (AST)
pathway; (2) from anaerobic respiration where fumarate,
produced from aspartate, acts as an electron acceptor; and (3)
from spermine, spermidine, and/or putrescine degradation (via
GABA). There is therefore evidence for a modest change in
anaerobic respiration, that is, cellular aspartate is depleted and
succinate increased, which may contribute to the observed
change in MIC. However, the strongest correlation with the
reduced MIC is with 1,3-diaminopropane and an N-acetyl
resonance. Whether through stimulation of anaerobic respira-
tion or, more likely, an uncharacterized, nonspecific direct effect,
formate addition stimulates polyamine degradation. In P.
aeruginosa, polyamines are responsible for resistance to cationic
peptides, aminoglycosides, and quinolone antibiotics53 but are
also protective from oxidative stress when localized at the cell
surface.54 Genes required for the production of polyamines are
also transcribed under the control of the PmrAB two-
component system, associated with resistance to both colistin
and aminoglycosides,55 and spermidine synthase is part of the
same gene operon.56 There may therefore be a link between
oxidative stress, the need for polyamine synthesis, and
concomitant reduced sensitivity to cationic antimicrobials but
we did not see any mitigation of ROS on addition of formate,
using the DCFH-DA fluorescent probe.
Because formate and other organic acids may be responsible
for modestly increased sensitivity to cationic antimicrobials in
vitro, there are now questions as to how this is achieved, whether
their addition might be a useful modification to susceptibility
testing media, and whether it has any relevance to the in vivo
infection setting?
Organic acids are capable of crossing the bacterial plasma
membrane, being protonated or deprotonated but also
complexing with transition metals. Organic acids have been
shown to shuttle transitionmetals into bacteria and this has been
exploited to inhibit the growth of bacterial pathogens.57 Such
activity may deplete extracellular and surface associated zinc,
nickel and iron while enriching these within the bacteria. Future
work may therefore explore whether and how the wide-ranging
effects of this process influences the production of polyamines
by P. aeruginosa or otherwise influences the activity of
membrane active antimicrobials.
Consistent with the lack of a substantial shift in metabolic
strategy on the addition of formate to RPMI in the present study,
formate dehydrogenase encoding genes are found to be
repressed in P. aeruginosa from CF sputum,8 and hence formate
is therefore probably not a key electron donor in the pulmonary
lung infection setting. There is however ample evidence from
NMR studies that formate and acetate are present in substantial
quantities in the lung,58−61 while propionate liberated by mucin
fermenting anaerobes may support growth of P. aeruginosa in CF
sputum.61 This study therefore suggests the possibility that
readily available organic acids may be expected to have modest
potentiating effects on colistin and aminoglycosides and may
influence therapeutic outcomes.
■ CONCLUSION
Bacterial culture conditions are known to have a substantial
impact on antibacterial susceptibility testing. Here, we
characterize the effect of three key nutrients on the susceptibility
of P. aeruginosa to membrane active components. In addition to
the combination of Ca2+ and Mg2+ divalent cations, which
induce a substantial change in cell wall composition, glucose is
shown to make a small contribution to antimicrobial tolerance
through an osmotic effect. Formate, a common component of
bacteriological media but absent from cell culture media, is
linked to metabolism of polyamines and, in common with other
organic acids, was shown to have a sensitizing impact on the
activity of colistin and the aminoglycoside tobramycin. The
presence of organic acids in, for example, the mammalian lung
suggests these might be a useful addition to future generations of
media used for antibacterial susceptibility testing.
■ METHODS
Media. Mueller-Hinton Broth (MHB, Oxoid CM405), low
salt Luria−Bertani (LB, Sigma L3397) broth, Tryptone Soya
Broth (TSB, Oxoid CM0129), and Roswell Park Memorial
Institute 1640 (RPMI, Gibco 51800035) broth were prepared
by solubilizing the amount of powder suggested by the
manufacturer in ultrapure water. RPMI is a defined medium,
and its complete formulation is available from the manufacturer.
The precise composition of MHB, LB, and TSB is unknown
other than (1) MHB contains dehydrated infusion from beef
(300 g/L), casein hydrolysate (17.5 g/L), and starch (1.5 g/L);
(2) LB contains NaCl (0.5 g/L), tryptone (10 g/L), and yeast
extract (5 g/L); and (3) TSB contains pancreatic digest of casein
(17 g/L), enzymatic digest of soya bean (3 g/L), NaCl (5 g/L),
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K2HPO4 (2.5 g/L), and glucose (2.5 g/L). MHB, LB, and TSB
were autoclaved at 121 for 15 min. Five percent of FBS was
added to RPMI media, and this was filtered through a 0.22 μm
membrane. Cation adjusted MHB (CAMHB) was prepared
according to CLSI guidelines by supplementing MHB to a final
concentration of 20−25 mg/L Ca2+ and 10−12.5 mg/L Mg2+.1
Cations were added after sterilization of the media from CaCl2
and MgCl2 sterile stock solutions, as described in the
guidelines.1
Bacterial Growth Conditions. E. coli NCTC 9001 and P.
aeruginosa PAO1 were streaked on differently composed agar
plates according to the media to be tested (MHB, CAMHB, LB,
Tryptic Soy Agar (TSA), and RPMI with 5% FBS) and
incubated at 37 °C overnight. A further selection of five
multidrug-resistant (MDR) and susceptible clinical P. aeruginosa
isolates were streaked on agar plates composed of either
Mueller-Hinton or RPMI with 5% FBS: water supply in neonatal
ward (372261), sputum (CAS2), bronchial alveolar lavage
(CAS3), wound (CAS4), and cystic fibrosis (GH12, MDR)
strains. Strains are representative of both of the major P.
aeruginosa clades described by Freschi et al. with 372261, CAS2
and CAS4 being closely related to PAO1 and CAS3 and GH12
being more similar to the PA14 type strain.62 Single colonies
were used to inoculate a defined volume (depending on the
technique to be used) of respective media broth and incubated
overnight at 37 °C without shaking. The same conditions were
used to characterize the response of P. aeruginosa to different
media components. MHB was supplemented with seven
increasing concentrations of Mg2+/Ca2+, glucose (see Figures
S5A and S6A) and RPMI with increasing concentrations of
sodium formate. These broths were used to prepare P. aeruginosa
cultures.
Antibacterial Activity Assay. Bacteria were grown over-
night in 5 mL of respective media without shaking at 37 °C. The
antibacterial activity was assessed through a modified two-fold
broth microdilution assay, as described before.27 The method
broadly followed EUCAST methodology with noncation
adjusted Mueller Hinton, LB, TSB, and RPMI being used in
addition to cation-adjusted Mueller Hinton. The MIC50
reported for each peptide in Table 1 is the average of at least
three biological replicate experiments performed as follows:
briefly, a two-fold dilution of peptide or antibiotic stock
solutions was performed in a 96-well polypropylene microtiter
plate. Then, 50 μL of a bacterial suspension (back diluted from
overnight cultures to an A620 of 0.001) were added to 50 μL of
peptide solution in each well of the plate reaching a final volume
of 100 μL. Growth and sterility controls were present for each
experiment. The plate was sealed with a sticker and incubated at
37 °C for 18 h without shaking. Bacterial growth was observed
with a colorimetric assay. Twenty microliters of a resazurin
solution (0.2 g/L) was added to each well, and the plate was
incubated for an additional 2 h. The results were read at A570
and A600 (pink and blue color, respectively) on a microplate
reader (Molecular Devices SpectraMax 340 PC Microplate
Reader) and plotted as the difference in absorbance versus
peptide concentrations. The plot obtained was fitted with a
sigmoidal curve to obtain the concentration necessary to inhibit
the growth of 50% of bacteria (MIC50). The data in Table 3 are
modal MICs generated from at least three biological replicate
experiments, performed as above with the following modifica-
tions: where appropriate, RPMI (5% FBS) was doped with 40
mM sodium formate, sodium acetate, sodium butyrate, sodium
citrate or sodium propionate; plates were incubated, static at 37
°C, for 20 h, and the OD600 was determined using a Clariostar
plate reader (BMG Labtech); theMIC was defined as the lowest
concentration where growth was <0.1 above the background
absorbance. Modification, with the sodium salt of the various
organic acids, did not significantly alter the pH of the media.
NMR Metabolomics. On three separate occasions, three
distinct colonies were picked and overnight cultures (n = 9)
were grown in 10 mL of the respective media, reaching
stationary phase, and pelleted at 5000 rpm and 4 °C.
Supernatant was collected and filtered through 0.22 μm
membrane filters to remove remaining bacterial cells. The
bacterial pellet was centrifuged twice at 10 000 rpm in order to
remove as much media as possible. Pellets were snap frozen in
liquid nitrogen before freeze-drying using an Alpha 1-2 LD plus
freeze-dryer (Martin Christ, Germany) and resuspended in 40
μL ofD2O. The resuspended samples were placed in Kel-F insert
and then in the 4 mm zirconia magic angle spinning (MAS)
rotor and preserved with a Kel-F cap (Bruker, Rheinstetten,
Germany). Data acquisition was performed on a 600 MHz
Bruker Avance III spectrometer equipped with a 4mmHR-MAS
probe, keeping the temperature at 310 K. Spinning speed was 5
kHz. 1H NMR spectra were collected with a Carr-Purcell
Meiboom-Gill presaturation (cpmgpr1d) pulse sequence with a
spectrum width of 16.0 ppm and 9615 data points using 64
transients. Free induction decay was multiplied by an
exponential function with line broadening of 0.3 Hz.
For the analysis of the spent media, 500 μL of each
supernatant sample was supplemented with 10% D2O
containing 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium
salt (TSP-d4) to provide a deuterium lock signal with reference
signal. Samples were then transferred to NMR tubes. Samples of
fresh media for each condition were treated and analyzed
following the same protocol. Samples were pH adjusted before
running NMR experiments. 1H NMR spectra were recorded on
a Bruker 600 MHz Bruker Avance III NMR spectrometer
(Bruker BioSpin, Coventry, United Kingdom) equipped with a 5
mm 1H, 13C, 15N TCI Prodigy Probe and a cooled sample
changer with 10 sample replicates tested per condition and all
kept at 4 °C. The 1D spectra were recorded under automation at
298 K using a Carr−Purcell−Meiboom−Gill presaturation
(cpmgpr1) pulse sequence. Spectra were acquired with 32
transients, a spectrum width of 19.83 ppm and 65 536 data
points. For both liquid state and HR-MAS, correlation
spectroscopy (COSY), total correlation spectroscopy
(TOCSY), and 1H−13C heteronuclear single quantum correla-
tion (HSQC) spectra were acquired for a subset of samples to
aid the assignment of metabolite resonance. All peak positions
were measured relative to the methyl peak of TSP-d4 set to 0.0
ppm.
Data Analysis and Statistics. The spectra were Fourier
transformed automatically using standard Bruker commands
and manually phased and baseline corrected in Bruker TopSpin
4.0 (Bruker Biospin, Coventry, U.K.).Metabolites were assigned
using the databanks: Chenomx NMR suite software (Chenomx
Inc., Canada), Human Metabolome Database (HMDB),
Biological Magnetic Resonance Data Bank (BMRB),63 E. coli
Metabolome Database (ECMDB), and AOCS lipid library; and
a comparison of chemical shifts to the literature, which was
confirmed using 2D NMR spectra. The intensities of assigned
NMR peaks were analyzed using nonparametric univariate
methods. Volcano plots compared the fold change in metabolite
values between two conditions. Fold change was calculated as
the ratio between each media andMHB. Mann−Whitney U test
ACS Infectious Diseases pubs.acs.org/journal/aidcbc Article
https://doi.org/10.1021/acsinfecdis.1c00002
ACS Infect. Dis. XXXX, XXX, XXX−XXX
K
was used to compare means, and associated p-values were False
Discovery rate adjusted using the Benjamini−Hochbergmethod
(α = 0.05). Volcano plots were generated using custom scripts in
Python with Numpy, Pandas, Matplotlib, and Seaborn packages.
Box plots were generated using changes in normalized intensity
for each metabolite, and significant differences between
challenges and controls were determined using a one way-
ANOVA. Data were treated with probabilistic quotient
normalization (PQN) before the analysis.64 PLS Regression
was performed in Python using the PLSRegression function in
the scikit-learn software package. Initial model assessment
determined that only one component was necessary for best
model performance. Increased number of components led to a
decrease in Q2. Monte Carlo cross-validation of models was
performed by randomly splitting data into 70/30 training/test
set splits. Model generation and assessment was repeated 1000
times to avoid bias by sample separation and R2 and Q2 values
were calculated to assess model performance. The R2 metric
demonstrates how well the model describes the training data set
while Q2 is a metric of how well the model predicts the test set.
Transmission Electron Microscopy. Control and chal-
lenge samples were grown as above for NMR metabolomics
studies. Pellets were then washed with 2.5% glutaraldehyde in
cacodylate buffer (with supplemented glucose for the RPMI
sample) and fixed in the same buffer overnight at 4 °C. Samples
were prepared and imaged as follows: samples were osmicated in
1% osmium tetroxide in cacodylate buffer for 1.5 h at 4 °C and
then washed twice with distilled water. Samples were stained
with 1% uranyl acetate in water for 1 h at room temperature and
washed again in distilled water before dehydrating in a graded
ethanol series. Preinfiltration with propylene oxide was carried
out twice, both for 10 min, before samples were infiltrated with a
series of SPURR resin/propylene oxide mixture followed by
infiltration of 100% SPURR resin for 24 h. Samples were then
embedded and polymerized for 24 h at 60 °C. Images were
acquired using a JEOL JEM-1400Plus microscope at 120 kV
with a JEOL Ruby camera (JEOL, U.S.A.).
2,7-Dichlorodihydrofluorescein Diacetate (DCFH-DA)
Fluorescence. P. aeruginosa PAO1 was cultured overnight at
37 °C in either MHB or RPMI (5% FBS) in the presence and
absence of either 5 mM or 40 mM sodium formate. Samples
were pelleted by centrifugation and diluted to an OD600 of 0.6 in
phosphate buffered saline (PBS). The cell suspension was
incubated in darkness for 1 h at 37 °C with 5 μM DCFH-DA.
Upon completion of incubation, the cell suspension was washed
with PBS to remove excess dye and incubated in darkness at 37
°C for 5min to equilibrate. Fluorescence spectra (515−545 nm)
were obtained using a Varian Cary Eclipse fluorescence
spectrometer at 37 °C with excitation at 485 nm.
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